P38 MAPK inhibition is critically involved in VEGFR-2-mediated endothelial cell survival

Biochemical and Biophysical Research Communications

Volumn 306, Issue 3, 2003, Pages 730-736

  Yilmaz, Ali ^a   Kliche, Stefanie ^a   Mayr Beyrle, Ulrike ^a   Fellbrich, Guido ^a   Waltenberger, Johannes ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

Author keywords

Apoptosis; Caspase 3; p38 MAPK; Signal transduction; VEGF

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CASPASE 3; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; CASP3 PROTEIN, HUMAN; CASPASE; ENDOTHELIAL CELL GROWTH FACTOR; IMIDAZOLE DERIVATIVE; LYMPHOKINE; MITOGEN ACTIVATED PROTEIN KINASE P38; PYRIDINE DERIVATIVE; SIGNAL PEPTIDE; VASCULOTROPIN A;

ANGIOGENESIS; APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; CULTURE MEDIUM; CYTOLOGY; DRUG ANTAGONISM; METABOLISM; PHYSIOLOGY;

APOPTOSIS; CASPASE 3; CASPASES; CELL SURVIVAL; CULTURE MEDIA, SERUM-FREE; ENDOTHELIAL GROWTH FACTORS; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; IMIDAZOLES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LYMPHOKINES; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0041630601     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01064-7     Document Type: Article

References (55)

1. Achen M.G., Jeltsch M., Kukk E., Makinen T., Vitali A., Wilks A.F., Alitalo K., Stacker S.A. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc. Natl. Acad. Sci. USA. 95:1998;548-553.
2. Alon T., Hemo I., Itin A., Pe'er J., Stone J., Keshet E. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity. Nat. Med. 1:1995;1024-1028. Balsari A., Maier J.A.M., Colnaghi M.I., Menard S. Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma. Lab. Invest. 79:1999;897-902.
3. Balsari A., Maier J.A.M., Colnaghi M.I., Menard S. Correlation between tumor vascularity, vascular endothelial growth factor production by tumor cells, serum vascular endothelial growth factor levels, and serum angiogenic activity in patients with breast carcinoma. Lab. Invest. 79:1999;897-902.
4. Bellamy W.T., Richter L., Frutiger Y., Grogan T.M. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies. Cancer Res. 59:1999;728-733.
5. Berse B., Brown L.F., van de Water L., Dvorak H.F., Senger D.R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell. 3:1992;211-220.
6. Brown L.F., Berse B., Jackman R.W., Tognazzi K., Manseau E.J., Dvorak H.F., Senger D.R. Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Am. J. Path. 143:1993;1255-1262. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:1996;435-439.
7. Carmeliet P., Ferreira V., Breier G., Pollefeyt S., Kieckens L., Gertsenstein M., Fahrig M., Vandenhoeck A., Harpal K., Eberhardt C., Declercq C., Pawling J., Moons L., Collen D., Risau W., Nagy A. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:1996;435-439.
8. Carmeliet P. Mechanisms of angiogenesis and arteriogenesis. Nat. Med. 6:2000;389-395.
9. Clauss M., Gerlach M., Gerlach H., Brett J., Wang F., Familletti P., Pan Y.-C., Olander J.V., Conolly D.T., Stern D. Vascular permeability factor: a tumor derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J. Exp. Med. 172:1990;1535-1545.
10. Deacon K., Blank J.L. MEK kinase 3 directly activates MKK6 and MKK7, specific activators of the p38 and c-Jun NH2-terminal kinases. J. Biol. Chem. 274:1999;16604-16610.
11. Eichmann A., Pardanaud L., Yuan L., Moyon D. Vasculogenesis and the search for the hemangioblast. J. Hematother. Stem. Cell Res. 11:2002;207-214.
12. Ferrara N., Carver-Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell-Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:1996;439-440.
13. Ferrara N., DavisSmyth T. The biology of vascular endothelial growth factor. Endocrine Rev. 18:1997;4-25.
14. Ferrara N., Wilner J., Burton T. Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors. 5:1991;141-148.
15. Folkman J. The role of angiogenesis in tumor growth. Semin. Cancer Biol. 3:1992;65-71.
16. Fujio Y., Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage dependent manner. J. Biol. Chem. 274:1999;16349-16354.
17. Gerber H.P., Dixit V., Ferrara N. Vascular endothelial growth factor induces expression of the antiapoptotic proteins Bcl-2 and A1 in vascular endothelial cells. J. Biol. Chem. 273:1998;13313-13316.
18. ′ -kinase/Akt signal transduction pathway J. Biol. Chem. 273:1998;30336-30343.
19. Ghatan S., Larner S., Kinoshita Y., Hetman M., Patel L., Xia Z., Youle R.J., Morrison R.S. p38 MAP kinase mediates bax translocation in nitric oxide-induced apoptosis in neurons. J. Cell Biol. 150:2000;335-347.
20. Gratton J.-P., Morales-Ruiz M., Kureishi Y., Fulton D., Walsh K., Sessa W.C. Akt-down regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J. Biol. Chem. 276:2001;30359-30365.
21. Guo D., Jia Q., Song H.Y., Warren R.S., Donner D.B. Vascular endothelial cell growth factor promotes tyrosine phosphorylation of mediators of signal transduction that contain SH2 domains. Association with endothelial cell proliferation. J. Biol. Chem. 270:1995;6729-6733.
22. Harris S.R., Schoeffner D.J., Yoshiji H., Thorgeirsson U.P. Tumor growth enhancing effects of vascular endothelial growth factor are associated with increased nitric oxide synthase activity and inhibition of apoptosis in human breast carcinoma xenografts. Cancer Lett. 179:2002;95-101.
23. Hashimoto S., Matsumoto K., Gon Y., Maruoka S., Takeshita I., Hayashi S., Koura T., Kujime K., Horie T. p38 Mitogen-activated protein kinase regulates IL-8 expression in human pulmonary vascular endothelial cells. Eur. Respir. J. 13:1999;1357-1364.
24. Heldin C.-H. Dimerization of cell surface receptors in signal transduction. Cell. 80:1995;213-223.
25. Hyman K.M., Seghezzi G., Pintucci G., Stellari G., Kim J.H., Grossi E.A., Galloway A.C., Mignatti P. Transforming growth factor-beta1 induces apoptosis in vascular endothelial cells by activation of mitogen-activated protein kinase. Surgery. 132:2002;173-179.
26. Jimenez B., Volpert O.V., Crawford S.E., Febbraio M., Silverstein R.L., Bouck N. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1. Nat. Med. 6:2000;41-48.
27. Joukov V., Pajusola K., Kaipainen A., Chilov D., Lahtinen I., Kukk E., Saksela O., Kalkkinen N., Alitalo K. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinase. EMBO J. 15:1996;290-298.
28. Keck P.M., Hauser S.D., Krivi G., Sanzo K., Warren T., Feder J., Connolly D.T. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science. 246:1989;1309-1312.
29. Kroll J., Waltenberger J. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J. Biol. Chem. 272:1997;32521-32527.
30. Kroll J., Waltenberger J. VEGF-A induces expression of eNOS and iNOS in endothelial cells via VEGF receptor-2 (KDR). Biochem. Biophys. Res. Commun. 252:1998;743-746.
31. Kroll J., Waltenberger J. A novel function of VEGF receptor-2 (KDR): rapid release of nitric oxide in response to VEGF-A stimulation in endothelial cells. Biochem. Biophys. Res. Commun. 265:1999;636-639.
32. Kroll J., Waltenberger J. Regulation der Endothelfunktion und der Angiogenese durch den Vaskulären Endothelialen Wachstumsfaktor-A (VEGF-A). Z. Kardiol. 89:2000;206-218.
33. Kyriakis J.M., Avruch J. Protein kinase cascades activated by stress and inflammatory cytokines. Bioessays. 18:1996;567-577.
34. Liu W.L., Guo X., Chen Q.Q., Guo Z.G. VEGF protects bovine aortic endothelial cells from TNF-alpha- and H(2)O(2)-induced apoptosis via co-modulatory effects on p38- and p42/p44-CCDPK signalling. Acta Pharmacol. Sin. 23:2002;45-49.
35. Liu Z.Y., Ganju R.K., Wang J.F., Ona M.A., Hatch W.C., Zheng T., Avraham S., Gill P., Groopmann J.E. J. Clin. Invest. 99:1997;1798-1804.
36. Meredith J.E., Fazeli B., Schwartz M.A. The extracellular matrix as a cell survival factor. Mol. Biol. Cell. 4:1993;953-961.
37. Nakagami H., Morishita R., Yamamoto K., Yoshimura S.I., Taniyama Y., Aoki M., Matsubara H., Kim S., Kaneda Y., Ogihara T. Phosphorylation of p38 mitogen-activated protein kinase downstream of bax-caspase-3 pathway leads to cell death induced by high D-glucose in human endothelial cells. Diabetes. 50:2001;1472-1481.
38. O'Connor D.S., Schechner J.S., Adida C., Mesri M., Rothermel A.L., Li F., Nath A.K., Pober J.S., Altieri D.C. Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am. J. Pathol. 156:2000;393-398.
39. Ogawa S., Oku A., Sawano A., Yamaguchi S., Yazaki Y., Shibuya M. A novel type of vascular endothelial growth factor VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain. J. Biol. Chem. 273:1998;31273-31282.
40. Olofsson B., Korpelainen E., Pepper M.S., Mandriota S.J., Aase K., Kumar V., Gunji Y., Jeltsch M.M., Shibuya M., Alitalo K., Eriksson U. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc. Natl. Acad. Sci. USA. 95:1998;11709-11714.
41. Ono K., Han J. The p38 signal transduction pathway: activation and function. Cell Signal. 12:2000;1-13.
42. Otani A., Kinder K., Ewalt K., Otero F.J., Schimmel P., Friedlander M. Bone marrow-derived stem cells target retinal astrocytes and can promote or inhibit retinal angiogenesis. Nat. Med. 8:2002;1004-1010.
43. Rees M., Hague S., Oehler M.K., Bicknell R. Regulation of endometrial angiogenesis. Climacteric. 2:1999;52-58.
44. Risau W. Mechanisms of angiogenesis. Nature. 386:1997;671-674.
45. Rousseau S., Houle F., Landry J., Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene. 15:1997;2169-2177.
46. Shibuya M., Yamaguchi S., Yamane A., Ikeda T., Tojo A., Matsushime H., Sato M. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 5:1990;519-524.
47. Takahashi M., Okazaki H., Ogata Y., Takeuchi K., Ikeda U., Shimada K. Lysophosphatidylcholine induces apoptosis in human endothelial cells through a p38-mitogen-activated protein kinase-dependent mechanism. Atherosclerosis. 161:2002;387-394.
48. Terman B.I., Carrion M.E., Kovacs E., Rasmussen B.A., Eddy R.L., Shows T.B. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene. 6:1991;1677-1683.
49. Thakker G.D., Hajjar D.P., Muller W.A., Rosengart T.K. The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signalling. J. Biol. Chem. 274:1999;10002-10007.
50. Tran J., Rak J., Sheehan C., Saibil S.D., LaCasse E., Korneluk R.G., Kerbel R.S. Marked induction of the IAP antiapoptotic proteins survivin and XIAP by VEGF in vascular endothelial cells. Biochem. Biophys. Res. Commun. 264:1999;781-788.
51. Waltenberger J. Modulation of growth factor action: implications for the treatment of cardiovascular diseases. Circulation. 96:1997;4083-4094.
52. Waltenberger J., Claesson-Welsh L., Siegbahn A., Shibuya M., Heldin C.-H. Different signal transduction properties of KDR and Flt-1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269:1994;26988-26995.
53. Wilting J., Birkenhager R., Eichmann A., Kurz H., Martinybaron G., Marme D., McCarthy J.E.G., Christ B., Weich H.A. VEGF(121) induces proliferation of vascular endothelial cells and expression of flk-1 without affecting lymphatic vessels of the chorioallantoic membrane. Dev. Biol. 176:1996;76-85.
54. Yue T.L., Ni J., Romanic A.M., Gu J.L., Keller P., Wang C., Kumar S., Yu G.L., Hart T.K., Wang X., Xia Z., DeWolf W.E., Feuerstein G.Z. TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) caspase-3-like protease. J. Biol. Chem. 274:1999;1479-1486.
55. Zachary I., Gliki G. Signaling transduction mechanism mediating biological actions of the vascular endothelial growth factor family. Cardiovasc. Res. 49:2001;568-581.